N/A Completed N=80 Health Services Research

Treatment Phenotypes for Adolescents With Asthma

Asthma · Adherence, Treatment

Source: ClinicalTrials.gov NCT04228107 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Nov 2025

Primary outcomePrimary: Treatment Phenotypes — 7; 2; 10; 5 Participants

Summary

This study will evaluate how adolescents take their asthma medications using an electronic medication monitor.

Outcome Measures

Outcome	Result	p-value
PRIMARY Treatment Phenotypes	7; 2; 10; 5; 16; 3	—
SECONDARY Qualitative Information Regarding Barriers for Medication Use	5; 5; 7	—
SECONDARY Qualitative Information Regarding Facilitators for Medication Use	5; 7	—

Eligibility Criteria

For adolescent participants:

Inclusion Criteria

Diagnosis of asthma On an inhaled controller and rescue medication for which a propeller health device is available

Exclusion Criteria

Other significant chronic lung disease (from problem list)
Cystic fibrosis
Chronic respiratory failure
Tracheostomy status
Intersititial lung disease
Significant developmental delay
Taking more than 3 asthma related medications
Primary language other than English, Spanish, Catalan, Dutch, French, German or Italian

Healthcare providers will be recruited as well to participate in focus groups as part of specific aim 2.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04228107). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.